WHO ICTRP trial
PET/CT imaging of 64Cu labeled PSMA probes in patients with prostate cancer
ChiCTR2300079237 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300079237 |
|---|---|
| Public title | PET/CT imaging of 64Cu labeled PSMA probes in patients with prostate cancer |
| Scientific title | PET/CT imaging of 64Cu labeled PSMA probes in patients with prostate cancer |
| Primary sponsor | Affiliated Hospital of North Sichuan Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | prostate cancer |
| Interventions | Gold Standard:Pathology (surgical or puncture pathology) and/or imaging follow-up;Index test:SUVmax, %ID, TIAC, residence time |
| Registration date | Dec 28, 2023 |
| Target size | Target condition:30;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: